Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|May 29, 2026
NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasisMichela Di Filippo, Tugay Karakaya, Marta Slaufova, et al.
Molecular Cancer Therapeutics|June 28, 2015
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2Sandra N Freiberger, Phil F Cheng, Guergana Iotzova-Weiss, et al.
Oncotarget|October 30, 2016
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistanceMarieke I G Raaijmakers, Daniel S Widmer, Apurva Narechania, et al.
Cancer Immunology Research|July 15, 2020
Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK InhibitorsJessica L F Teh, Dan A Erkes, Phil F Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2021
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastasesMarie-Luise Hilbers, Florentia Dimitriou, Peter Lau, et al.
Cell Death & Disease|December 21, 2024
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosisBenjamin Loos, Adrian Salas-Bastos, Anna Nordin, et al.
Cell Reports|February 9, 2022
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cellsMariela Artola-Borán, Angela Fallegger, Martina Priola, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 14, 2023
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centresAlexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, et al.
Melanoma Research|May 17, 2017
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in SwitzerlandJoanna Mangana, Phil F Cheng, Corina Kaufmann, et al.
Genome Biology|April 18, 2015
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaPhil F Cheng, Olga Shakhova, Daniel S Widmer, et al.
Pageof 7